Briefings


Topic filters →
  • Accountability (2)
  • Social care (2)
  • Show All
Who decides the price and availability of NHS medicines? Outrage and dismay over the prices charged for new medicines are becoming an increasingly regular occurrence in England. Most recently it was over a life-extending drug for cystic fibrosis, Orkambi, with a hefty price tag of £105,000 per patient per year – far higher than NHS England’s counter offer of £500m over 5 years across all patients. The number of disputes between the... Read More